Complete response of penile mycosis fungoides with systemic brentuximab therapy

Mycosis fungoides with penile involvement is extremely rare. Previous reports have shown successful treatment with imiquimod or a combination of beam radiation and chemotherapy. We present a patient with mycosis fungoides and penile involvement. The penile lesions were initially treated with topical...

Full description

Bibliographic Details
Main Authors: Christian Schaufler, Katalin Ferenczi, Upendra Hegde, Benjamin T. Ristau
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Urology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214442020303491
id doaj-943ca4775e9243edb32aa8f05972eb5c
record_format Article
spelling doaj-943ca4775e9243edb32aa8f05972eb5c2020-12-15T04:09:37ZengElsevierUrology Case Reports2214-44202021-01-0134101460Complete response of penile mycosis fungoides with systemic brentuximab therapyChristian Schaufler0Katalin Ferenczi1Upendra Hegde2Benjamin T. Ristau3University of Connecticut Health Center, Division of Urology, 263 Farmington Avenue, Farmington, CT, 06030, United StatesUniversity of Connecticut Health Center, Division of Dermatology, 263 Farmington Avenue, Farmington, CT, 06030, United StatesUniversity of Connecticut Health Center, Division of Medicine, 263 Farmington Avenue, Farmington, CT, 06030, United StatesUniversity of Connecticut Health Center, Division of Urology, 263 Farmington Avenue, Farmington, CT, 06030, United States; Corresponding author. UConn Health – Urology Outpatient Pavilion, 7th floor 263 Farmington Avenue Farmington, CT, 06030, United States.Mycosis fungoides with penile involvement is extremely rare. Previous reports have shown successful treatment with imiquimod or a combination of beam radiation and chemotherapy. We present a patient with mycosis fungoides and penile involvement. The penile lesions were initially treated with topical imiquimod; however, he developed worsening glandular lesions and discharge. Therefore the treatment was discontinued. Subsequent treatment with brentuximab (anti-CD30) targeted therapy resulted in complete resolution of the penile lesions. To our knowledge, this represents the first case of a complete penile mycosis fungoides response to brentuximab therapy. Brentuximab may be considered for refractory penile mycoses fungoides.http://www.sciencedirect.com/science/article/pii/S2214442020303491Mycosis fungoidesBrentuximabAnti-CD30ImiquimodRemission
collection DOAJ
language English
format Article
sources DOAJ
author Christian Schaufler
Katalin Ferenczi
Upendra Hegde
Benjamin T. Ristau
spellingShingle Christian Schaufler
Katalin Ferenczi
Upendra Hegde
Benjamin T. Ristau
Complete response of penile mycosis fungoides with systemic brentuximab therapy
Urology Case Reports
Mycosis fungoides
Brentuximab
Anti-CD30
Imiquimod
Remission
author_facet Christian Schaufler
Katalin Ferenczi
Upendra Hegde
Benjamin T. Ristau
author_sort Christian Schaufler
title Complete response of penile mycosis fungoides with systemic brentuximab therapy
title_short Complete response of penile mycosis fungoides with systemic brentuximab therapy
title_full Complete response of penile mycosis fungoides with systemic brentuximab therapy
title_fullStr Complete response of penile mycosis fungoides with systemic brentuximab therapy
title_full_unstemmed Complete response of penile mycosis fungoides with systemic brentuximab therapy
title_sort complete response of penile mycosis fungoides with systemic brentuximab therapy
publisher Elsevier
series Urology Case Reports
issn 2214-4420
publishDate 2021-01-01
description Mycosis fungoides with penile involvement is extremely rare. Previous reports have shown successful treatment with imiquimod or a combination of beam radiation and chemotherapy. We present a patient with mycosis fungoides and penile involvement. The penile lesions were initially treated with topical imiquimod; however, he developed worsening glandular lesions and discharge. Therefore the treatment was discontinued. Subsequent treatment with brentuximab (anti-CD30) targeted therapy resulted in complete resolution of the penile lesions. To our knowledge, this represents the first case of a complete penile mycosis fungoides response to brentuximab therapy. Brentuximab may be considered for refractory penile mycoses fungoides.
topic Mycosis fungoides
Brentuximab
Anti-CD30
Imiquimod
Remission
url http://www.sciencedirect.com/science/article/pii/S2214442020303491
work_keys_str_mv AT christianschaufler completeresponseofpenilemycosisfungoideswithsystemicbrentuximabtherapy
AT katalinferenczi completeresponseofpenilemycosisfungoideswithsystemicbrentuximabtherapy
AT upendrahegde completeresponseofpenilemycosisfungoideswithsystemicbrentuximabtherapy
AT benjamintristau completeresponseofpenilemycosisfungoideswithsystemicbrentuximabtherapy
_version_ 1724382932054835200